About COGNITION THERAPEUTICS, INC.
Cognition Therapeutics, Inc. is a biotechnology company focused on developing therapies for age-related neurodegenerative diseases, such as Alzheimer’s disease and dementia with Lewy bodies. Their investigational therapy, zervimesine (CT1812), aims to protect brain synapses before irreversible neuronal decline.
Is this your company?
Claim COGNITION THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim COGNITION THERAPEUTICS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.